Studying clinical studies For many psychedelics companies, clinical trials are the most expensive part of their business model and the reason they need to raise so much capital. Finding…
invest in shroom stocks
Oura Rings I have an Oura Ring, I bought it a few years back to try and better understand my sleeping patterns. After a few months of use, I…
Shorter trips Remember early YouTube days when (insert activity here ______ on salvia) were some of the most popular videos on the internet? Well, it turns out salvia is…
Death & children’s novels When I think about Amanita Muscaria the first two things that come to mind are death, and children’s novels. Amanita Muscaria is arguably the…
The NYSE Cybin (CYBN.N) just finished its first trading day on the New York Stock Exchange (NYSE) after announcing the upcoming uplisting last month. It was a less…
Mushroom enthusiasts Filament Health (FH.NE) is looking at mushroom compounds far beyond just psilocybin as the company is run by actual mushroom enthusiasts with access to a lot of…
Multiple pivots Mind Cure (MCUR.C) began as a mushroom nootropic deal that has since shifted to ibogaine production and the development digital platforms. The company has been able to…